In a new study, researchers at Indiana University Bloomington have discovered a new way that bacteria can kill its ...

Researchers at Indiana University Bloomington have discovered a new way that bacteria can kill its competitors in complex microbial communities, revealing novel approaches to leverage viruses to kill ...

Promising clinical results observed in the first 88 patients evaluated so far, confirming the safety and an important clinical benefit for patients Control of the infection at 3 months for ...

Michael Scholle Appointed CEO of Tango Biosciences, the premier research partner for custom affinity reagents by phage ...

Israeli researchers have discovered a unique mechanism in marine bacteria that protects them from virus attacks, the Israel I ...

APSA-02 is under clinical development by Armata Pharmaceuticals and currently in Phase II for Bacteremia. According to GlobalData, Phase II drugs for Bacteremia have a 66% phase transition success ...

APPA-02 is under development for the treatment of multidrug-resistant chronic pulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients and non-CF bronchiectasis (NCFB). The drug ...

The human gut microbiome is complex and diverse, with significant implications for health and disease. The study develops ...

Researchers developed AbMAP, a cutting-edge framework leveraging transfer learning to model antibody hypervariable regions, ...

In a new book, a science journalist recounts the story of a lifesaving treatment for infection that scientists broadly ...